Section Arrow
PYXS.NASDAQ
- Pyxis Oncology
Quotes are at least 15-min delayed:2024/10/31 19:20 EDT
Last
 3.56
-0.21 (-5.57%)
Day High 
3.81 
Prev. Close
3.77 
1-M High
4.19 
Volume 
380.84K 
Bid
3.56
Ask
3.75
Day Low
3.56 
Open
3.77 
1-M Low
Market Cap 
224.02M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 3.66 
20-SMA 3.48 
50-SMA 3.57 
52-W High 6.85 
52-W Low 1.35 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.27/-1.20
Enterprise Value
244.12M
Balance Sheet
Book Value Per Share
2.86
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 19:20 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.